Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endocrine Testing Market Growth Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Endocrine Testing Industry Market Size Be by 2025?
In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. This growth in the historical period can be traced back to factors such as the identification of hormones and endocrine pathways, the standardization of diagnostic tests, public health campaigns, as well as patient advocacy and empowerment.

What's the Long-Term Growth Forecast for the Endocrine Testing Market Size Through 2029?
The market size for endocrine testing is projected to witness substantial expansion in the upcoming years. It is anticipated to reach a value of $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%. The growth during this projected period can be linked to factors such as the increasing incidences of endocrine disorders, higher defense expenditure, an aging demographic, improved awareness and provision for early diagnosis, as well as enhanced knowledge in the area. Key trends for this forecast period encompass advancements in the detection of biomarkers, integration of omics technologies, utilization of artificial intelligence and machine learning, assurance of quality and standardization, together with co-operative research and translational medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

What Are the Key Growth Drivers Fueling the Endocrine Testing Market Expansion?
The increasing incidence of diabetes is anticipated to drive the expansion of the endocrine testing market. Diabetes is characterized by an elevation in blood sugar (glucose) levels and is categorized into a set of diseases. The growth in diabetes cases is attributed to unhealthy eating habits, lack of physical activity, genetic factors, and an aging demographic. To diagnose diabetes, monitor glucose concentrations, and evaluate insulin production and sensitivity, endocrine tests like the hemoglobin A1c, fasting plasma glucose, and C-peptide tests are employed. For example, per the National Health Service (NHS), a UK government department, there was a noticeable increase in individuals below 40 years old, from 173,166 in 2022 to 216,440 in 2023. This significant increase underscores a worrisome trend in this demographic. The information suggests a swift surge in the occurrence of diabetes among the younger generations. Hence, the growing incidence of diabetes is spurring the growth of the endocrine testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What Are the Key Trends Driving Endocrine Testing Market Growth?
Key players in the endocrine testing market are revolutionizing their strategies by introducing point-of-care testing services to improve diagnosis efficiency and convenience of endocrine disorders. Quick-testing result options foster swift diagnostic procedures and management of heart failure symptoms like fatigue and shortness of breath in patients. In a case of this technological advancement, Swiss pharmaceutical giant, Roche Holding AG, unveiled a point-of-care NT-proBNP test in India in April 2024. This test specifically targets the screening of diabetes patients susceptible to cardiovascular diseases like heart failure (HF), aiming to pave the way for prompt detection and intervention. Such strategic approaches permit healthcare providers to promptly identify T2D patients at high risk and start necessary treatment discussions at the appropriate time. All of which contribute to better health outcomes and improved patient wellness.

How Is the Endocrine Testing Market Segmented?
The endocrine testing market covered in this report is segmented -

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test
10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

Which Companies Are Leading the Charge in Endocrine Testing Market Innovation?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Which Regions Are Leading the Global Endocrine Testing Market in Revenue?
North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.